Cargando…
Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019
Dexamethasone was shown to decrease the mortality in coronavirus disease-2019 (COVID-19) recently. Use of corticosteroids was harmful in other coronavirus infections previously. WHO recommended against routine use of corticosteroids in COVID-19. In view of these, we reviewed the evidence about the u...
Autores principales: | Rafiullah, Mohamed, Siddiqui, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694443/ https://www.ncbi.nlm.nih.gov/pubmed/33245242 http://dx.doi.org/10.2217/cer-2020-0146 |
Ejemplares similares
-
Dexamethasone: a corticosteroid drug for the treatment of coronavirus disease 2019
por: Riaz, Muhammad, et al.
Publicado: (2022) -
Facing coronavirus disease 2019: What do we know so far? (Review)
por: Guo, Qie, et al.
Publicado: (2021) -
Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review
por: Mehta, Jyoti, et al.
Publicado: (2022) -
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
por: Rabi, Firas A., et al.
Publicado: (2020) -
Coronavirus Disease 2019 and the Cerebrovascular‐Cardiovascular Systems: What Do We Know So Far?
por: Larson, Anthony S., et al.
Publicado: (2020)